Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom

Aileen Murphy; Elisabeth Fenwick; William D. Toff; Matthew P. Neilson; Colin Berry; Neal Uren; Keith G. Oldroyd; Andrew H. Briggs

doi:10.1017/S0266462312000670

Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom

Aileen Murphy
, Elisabeth Fenwick
, William D. Toff
, Matthew P. Neilson
, Colin Berry
, Neal Uren
, Keith G. Oldroyd
, Andrew H. Briggs

Cork University Business School

Research output: Contribution to journal › Article › peer-review

Abstract

Aortic stenosis (AS) is caused by age-related calcific degeneration of the aortic valve (1). Initially, cases are asymptomatic but, from the point that symptoms first develop, there is rapid progression and if left untreated survival estimates are low (2-3 years) (1). Therefore, managing AS effectively and efficiently is a priority for health systems with increasing healthcare costs and longer life expectancy.

Original language	English
Pages (from-to)	12-19
Number of pages	8
Journal	International Journal of Technology Assessment in Health Care
Volume	29
Issue number	1
DOIs	https://doi.org/10.1017/S0266462312000670
Publication status	Published - 2013

Keywords

Cost-effectiveness analysis
EVPI
EVPPI
TAVI
Value of information analysis

Access to Document

10.1017/S0266462312000670

Cite this

Murphy, A., Fenwick, E., Toff, W. D., Neilson, M. P., Berry, C., Uren, N., Oldroyd, K. G., & Briggs, A. H. (2013). Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom. International Journal of Technology Assessment in Health Care, 29(1), 12-19. https://doi.org/10.1017/S0266462312000670

@article{519e69c0f59f4656b3e6cc6dd427511a,

title = "Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom",

abstract = "Aortic stenosis (AS) is caused by age-related calcific degeneration of the aortic valve (1). Initially, cases are asymptomatic but, from the point that symptoms first develop, there is rapid progression and if left untreated survival estimates are low (2-3 years) (1). Therefore, managing AS effectively and efficiently is a priority for health systems with increasing healthcare costs and longer life expectancy.",

keywords = "Cost-effectiveness analysis, EVPI, EVPPI, TAVI, Value of information analysis",

author = "Aileen Murphy and Elisabeth Fenwick and Toff, \{William D.\} and Neilson, \{Matthew P.\} and Colin Berry and Neal Uren and Oldroyd, \{Keith G.\} and Briggs, \{Andrew H.\}",

year = "2013",

doi = "10.1017/S0266462312000670",

language = "English",

volume = "29",

pages = "12--19",

journal = "International Journal of Technology Assessment in Health Care",

issn = "0266-4623",

publisher = "Cambridge University Press",

number = "1",

}

Murphy, A, Fenwick, E, Toff, WD, Neilson, MP, Berry, C, Uren, N, Oldroyd, KG & Briggs, AH 2013, 'Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom', International Journal of Technology Assessment in Health Care, vol. 29, no. 1, pp. 12-19. https://doi.org/10.1017/S0266462312000670

Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom. / Murphy, Aileen; Fenwick, Elisabeth; Toff, William D. et al.
In: International Journal of Technology Assessment in Health Care, Vol. 29, No. 1, 2013, p. 12-19.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Transcatheter aortic valve implantation for severe aortic stenosis

T2 - The cost-effectiveness case for inoperable patients in the United Kingdom

AU - Murphy, Aileen

AU - Fenwick, Elisabeth

AU - Toff, William D.

AU - Neilson, Matthew P.

AU - Berry, Colin

AU - Uren, Neal

AU - Oldroyd, Keith G.

AU - Briggs, Andrew H.

PY - 2013

Y1 - 2013

N2 - Aortic stenosis (AS) is caused by age-related calcific degeneration of the aortic valve (1). Initially, cases are asymptomatic but, from the point that symptoms first develop, there is rapid progression and if left untreated survival estimates are low (2-3 years) (1). Therefore, managing AS effectively and efficiently is a priority for health systems with increasing healthcare costs and longer life expectancy.

AB - Aortic stenosis (AS) is caused by age-related calcific degeneration of the aortic valve (1). Initially, cases are asymptomatic but, from the point that symptoms first develop, there is rapid progression and if left untreated survival estimates are low (2-3 years) (1). Therefore, managing AS effectively and efficiently is a priority for health systems with increasing healthcare costs and longer life expectancy.

KW - Cost-effectiveness analysis

KW - EVPI

KW - EVPPI

KW - TAVI

KW - Value of information analysis

UR - https://www.scopus.com/pages/publications/84874486349

U2 - 10.1017/S0266462312000670

DO - 10.1017/S0266462312000670

M3 - Article

C2 - 23298511

AN - SCOPUS:84874486349

SN - 0266-4623

VL - 29

SP - 12

EP - 19

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

IS - 1

ER -

Transcatheter aortic valve implantation for severe aortic stenosis: The cost-effectiveness case for inoperable patients in the United Kingdom

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this